Rapid PCR test gets FDA emergency authorization

COVID-19 tests generally fall into two categories: rapid antigen tests, and slower but more accurate polymerase chain reaction tests.

Advertisement

The FDA granted emergency use authorization to a test that bucks those norms: a 15-minute PCR test, developed by researchers from Chicago-based Northwestern University’s Feinberg School of Medicine and Northwestern’s McCormick School of Engineering in Evanston, Ill., according to a news release.

The test, called the Diagnostic Analyzer for Specific Hybridization, is packaged in a device that’s about the size of a cereal box, the news release said. Users perform a single nasal swab, insert it into the device, and 15 minutes later a positive or negative result appears on the device’s touchscreen.

“DASH offers the accuracy of other PCR tests in a compact, portable platform that can be operated by non-technical personnel at the point-of-care in 15 minutes,” researcher Robert Murphy, MD, said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.